Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 181-188 , February 2001

Efficacy, safety, and use of snake antivenoms in the United States

Presented at the North American Congress of Clinical Toxicology’s “Advances in the Management of Snakebite” Symposium, October 1999, La Jolla, CA.

  • Richard C. Dart, MD, PhD

      Affiliations

    • Rocky Mountain Poison and Drug Center, Denver Health Authority, and the Department of Surgery, Medicine and Pharmacy, University of Colorado Health Sciences Center, Denver, CO
    • ,
  • Jude McNally, RPh, ABAT

      Affiliations

    • Arizona Poison and Drug Information Center, University of Arizona, Tucson, AZ.

Received 25 August 2000 ,Revised 29 November 2000 ,Accepted 5 December 2000.

References 

  1. Langley RL, Morrow WE. Deaths resulting from animal attacks in the United States. Wild Environ Med. 1997;8:8–16
  2. Parrish HM, Goldner JC, Silberg SL. Comparison between snakebites in children and adults. Pediatrics. 1965;36:251–256
  3. McDiarmid RW, Campbell JA, Toure TA. Snake Species of the World: A Taxonomic and Geographic Reference. In: Washington, DC: : The Herpetologists’ League; 1999;p. 234–351
  4. Russell FE. Snake Venom Poisoning. Great Neck, NY: : Scholium International, Inc; 1983;
  5. Willson P. Snake poisoning in the United States: a study based on analysis of 740 cases. In: Arch Intern Med; 1908;p. 516–570
  6. Dart RC. Sequelae of pit viper envenomation. In:  Campbell JA,  Brodie ED editor. Biology of the Pit Vipers. Tyler, TX: : Selva Publishing; 1992;p. 395–404
  7. Lindsey D. Controversy in snakebite—time for a controlled appraisal. J Trauma. 1985;25:462–463
  8. Otero-Patino R, Cardoso JL, Higashi HG, et al.  A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The Regional Group on Antivenom Therapy Research (REGATHER). Am J Trop Med Hyg. 1998;58:183–189
  9. Warrell DA, Looareesuwan S, Theakston DG, et al.  Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calleoselasma rhodostoma) in southern Thailand: clinical and laboratory correlations. Am J Trop Med Hyg. 1986;35:1235–1237
  10. Burch JM, Agarwal R, Mattox KL, et al.  The treatment of crotalid envenomation without antivenin. J Trauma. 1988;28:35–43
  11. Dart RC, Garcia RA, Hurlbut KM, et al.  Development of a severity score for the assessment of crotalid snakebite. Ann Emerg Med. 1996;27:321–326
  12. Seegers WH, Ouyang C. Snake venoms and blood coagulation. In:  Lee C-Y editors. Snake Venoms. New York, NY: : Springer-Verlag; 1979;p. 684–750
  13. Ohsaka A. Hemorrhagic, necrotizing and edema-forming effects of snake venoms. In:  Lee C-Y editors. Snake Venoms. New York, NY: : Springer-Verlag; 1979;p. 480–546
  14. Russell FE, Ruzic N, Gonzalez H. Effectiveness of antivenin (Crotalidae) polyvalent following injection of Crotalus venom. Toxicon. 1973;11:461–464
  15. Dart RC, Goldner A, Lindsey D. Efficacy of post envenomation administration of antivenin. Toxicon. 1988;26:1218–1221
  16. Davidson TM. Intravenous rattlesnake envenomation. West J Med. 1988;148:45–47
  17. Jurkovich GJ, Luterman A, McCullar K, et al.  Complications of Crotalidae antivenin treatment. J Trauma. 1988;28:1032–1037
  18. Wingert WA, Chan L. Rattlesnake bites in southern California and rationale for recommended treatment. West J Med. 1988;148:37–44
  19. Wagner CW, Golladay ES. Crotalid envenomation in children: selective conservative management. J Pediatr Surg. 1989;24:128–131
  20. Weber RA, White RR. Crotalidae envenomation in children. Ann Plast Surg. 1993;31:141–145
  21. Gold BS, Wingert WA. Snake venom poisoning in the United States: a review of therapeutic practice. South Med J. 1994;87:579–589
  22. Bond GR, Burkhart KK. Thrombocytopenia following timber rattlesnake envenomation. Ann Emerg Med. 1997;30:40–44
  23. Bush SP, Jansen PW. Severe rattlesnake envenomation with anaphylaxis and rhabdomyolysis. Ann Emerg Med. 1995;25:845–848
  24. Huang TT, Blackwell SJ, Lewis SR. Hand deformities in patients with snakebite. Plast Reconstruct Surg. 1978;62:32–36
  25. Glass TG. Early debridement in pit viper bite. Surg Gynecol Obstet. 1973;136:774–776
  26. Consroe P, Egen NB, Russell RE, et al.  Comparison of a new ovine antigen binding fragment (Fab) for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. Am J Trop Med Hyg. 1995;53:507–510
  27. Dart RC, Seifert SA, Carroll L, et al.  Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39
  28. Bogdan GM, McKinney P, Porter RS, et al.  Clinical efficacy of two dosing regimens of affinity purified mixed monospecific crotalid antivenom ovine Fab (CroTAb) [abstract]. Acad Emerg Med. 1997;4:518
  29. Hardy DL, Jeter M, Corrigan JJ. Envenomation by the northern blacktail rattlesnake (Crotalus molossus molossus): report of two cases and the in vitro effects of the venom on fibrinolysis and platelet aggregation. Toxicon. 1982;20:487–493
  30. Gillissen A, Theakston RD, Barth J, et al.  Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw-scaled or carpet viper (Echis ‘pyramidum’-complex): failure of antivenom treatment. Toxicon. 1994;32:937–944
  31. Theakston RDG, Phillips RE, Warrell DA, et al.  Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom. Trans Royal Soc Trop Med Hyg. 1990;34:301–308
  32. Bogdan GM, Dart RC, Falbo SC, et al.  Recurrent coagulopathy after antivenom treatment of crotalid snakebite. South Med J. 2000;93:562–566
  33. Sullivan JB. Past, present and future immunotherapy of snake venom poisoning. Ann Emerg Med. 1987;16:938–944
  34. Steinberg EA, Russell FE, Underman AE. Preliminary clinical observations with prophylactic cyproheptadine hydrochloride in potential serum reactions to antivenins. In:  Rosenberg P editors. Toxin: Animal, Plant and Microbial. Oxford, England: : Pergamon Press; 1978;p. 489–493
  35. Corrigan P, Russell FE, Wainschel J. Clinical reactions to antivenin. Toxicon. 1978;1(Suppl):457–465
  36. Downey DJ, Omer GE, Moneim MS. New Mexico rattlesnake bites: demographic review and guidelines for treatment. J Trauma. 1991;31:1380–1386
  37. Grace TG, Omer GE. The management of upper extremity pit viper wounds. J Hand Surg. 1980;5:168–177
  38. Lopoo JB, Bealer JF, Mantor PC, et al.  Treating the snakebitten child in North America: a study of pit viper bites. J Pediatr Surg. 1998;33:1593–1595
  39. White RR, Weber RA. Poisonous snakebite in central Texas. Ann Surg. 1991;213:466–471
  40. Antivenin (Crotalidae) Polyvalent [Wyeth-Ayerst Laboratories]. In: 52nd ed. Physicians’ Desk Reference. Montvale, NJ: : Medical Economics; 1998;p. 3009–3010
  41. Hill RE, Bogdan GM, Dart RC. A comparison of reconstitution times for CroTAb and Antivenin (Crotalidae) Polyvalent [Wyeth] [abstract]. Toxicologist. 2000;54:171
  42. Decker WW, Bogdan GM, Garcia RA, et al.  Heat and motion stability of polyvalent crotalidae antivenin, ovine Fab. Toxicon. 1998;36:377–382

☆ Dr. Dart and Mr. McNally were clinical investigators in the trials of the experimental antivenom described in the text and were paid speakers in the symposium “Advances in the Management of Snakebite” that was sponsored by Savage Laboratories.

☆☆ Address for reprints: Richard C. Dart, MD, PhD, Rocky Mountain Poison and Drug Center, 1010 Yosemite Circle, Denver, CO 80230; 303-739-1100, fax 303-739-1119;,E-mail rdart@rmpdc.org .

PII: S0196-0644(01)65378-2

doi: 10.1067/mem.2001.113372

Annals of Emergency Medicine
Volume 37, Issue 2 , Pages 181-188 , February 2001

Article Tools

* Image Usage & Resolution